Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWAP: Switch or Add Pegylated-Interferon in Chronic Hepatitis B
NCT01928511Phase 4Completed
- Start
- Jan 2014
- Primary completion
- Dec 2018
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2b in Chronic Hepatitis B (CHB). Started Jan 2014; status: completed.
02
Drugs
peginterferon alfa-2b
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01928511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01928511.